Abstract

Introduction: Systemic Lupus Erythematosus (SLE) is a prototypical autoimmune disease characterized by the production of autoantibodies and the deposition of immune complexes in effected end organs. Both genetic and environmental factors appear to contribute to the development of systemic lupus erythematosus. One of the genetic factor effective in case is Mannose-Binding Lectin (MBL) gene. The aim of present study is to was determine the distribution of the alleles A, B, C, D and H, L, P, Q variants and Hy, Ly, Lx haplotype in Lupus patients had renal dysfunction in compare with normal control. Method: Twelve SLE patients with sever renal failure were compared with thirty normal control from Azarbaijan population of Iran. Frequency of alleles and genotypes were investigated by polymerase chain reaction and restriction fragment length polymorphism. Twelve SLE patients with sever renal failure were compared with thirty normal control from Azarbaijan population of Iran. Frequency of alleles and genotypes were investigated by polymerase chain reaction and restriction fragment length polymorphism. Results: Allelic and genotypic frequency of the polymorphism at position-550, +4 and at codon52,54 and 57 did not show statistical differences between SLE patient and controls but frequency of Lx haplotype was observed in patients with SLE and renal failure (p=0.0518). Allelic and genotypic frequency of the polymorphism at position-550, +4 and at codon52,54 and 57 did not show statistical differences between SLE patient and controls but frequency of Lx haplotype was observed in patients with SLE and renal failure (p=0.0518). Conclusions: Present findings showed that presence of Lx haplotype that cause low concentration of MBL in serum can be a risk factor for severity of systemic lupus erythematosus and susceptibility to renal dysfunction. Present findings showed that presence of Lx haplotype that cause low concentration of MBL in serum can be a risk factor for severity of systemic lupus erythematosus and susceptibility to renal dysfunction.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.